Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology
Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology
About this item
Full title
Author / Creator
Schilling, Stephan , Zeitschel, Ulrike , Hoffmann, Torsten , Heiser, Ulrich , Francke, Mike , Kehlen, Astrid , Holzer, Max , Hutter-Paier, Birgit , Prokesch, Manuela , Windisch, Manfred , Jagla, Wolfgang , Schlenzig, Dagmar , Lindner, Christiane , Rudolph, Thomas , Reuter, Gunter , Cynis, Holger , Montag, Dirk , Demuth, Hans-Ulrich and Rossner, Steffen
Publisher
United States
Journal title
Language
English
Formats
Publication information
Publisher
United States
Subjects
More information
Scope and Contents
Contents
Because of their abundance, resistance to proteolysis, rapid aggregation and neurotoxicity, N-terminally truncated and, in particular, pyroglutamate (pE)-modified Abeta peptides have been suggested as being important in the initiation of pathological cascades resulting in the development of Alzheimer's disease. We found that the N-terminal pE-forma...
Alternative Titles
Full title
Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology
Authors, Artists and Contributors
Author / Creator
Zeitschel, Ulrike
Hoffmann, Torsten
Heiser, Ulrich
Francke, Mike
Kehlen, Astrid
Holzer, Max
Hutter-Paier, Birgit
Prokesch, Manuela
Windisch, Manfred
Jagla, Wolfgang
Schlenzig, Dagmar
Lindner, Christiane
Rudolph, Thomas
Reuter, Gunter
Cynis, Holger
Montag, Dirk
Demuth, Hans-Ulrich
Rossner, Steffen
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_18836460
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_18836460
Other Identifiers
E-ISSN
1546-170X
DOI
10.1038/nm.1872
